DE60137352D1 - Nsalze, verfahren zur herstellung von beiden und ihre verwendung - Google Patents

Nsalze, verfahren zur herstellung von beiden und ihre verwendung

Info

Publication number
DE60137352D1
DE60137352D1 DE60137352T DE60137352T DE60137352D1 DE 60137352 D1 DE60137352 D1 DE 60137352D1 DE 60137352 T DE60137352 T DE 60137352T DE 60137352 T DE60137352 T DE 60137352T DE 60137352 D1 DE60137352 D1 DE 60137352D1
Authority
DE
Germany
Prior art keywords
sup
hydroxyl
lower alkoxy
present
nsalze
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60137352T
Other languages
English (en)
Inventor
Kenji Yamamoto
Yoshimitsu Suda
Tetsuji Asao
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kyushu University NUC
Original Assignee
Kyushu University NUC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyushu University NUC filed Critical Kyushu University NUC
Application granted granted Critical
Publication of DE60137352D1 publication Critical patent/DE60137352D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06104—Dipeptides with the first amino acid being acidic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0819—Tripeptides with the first amino acid being acidic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE60137352T 2000-11-06 2001-11-02 Nsalze, verfahren zur herstellung von beiden und ihre verwendung Expired - Lifetime DE60137352D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000338192 2000-11-06
PCT/JP2001/009621 WO2002036551A1 (fr) 2000-11-06 2001-11-02 Derives peptidiques et sels pharmaceutiquement acceptables de ceux-ci, procedes de preparation et d'utilisation associes

Publications (1)

Publication Number Publication Date
DE60137352D1 true DE60137352D1 (de) 2009-02-26

Family

ID=18813440

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60137352T Expired - Lifetime DE60137352D1 (de) 2000-11-06 2001-11-02 Nsalze, verfahren zur herstellung von beiden und ihre verwendung

Country Status (10)

Country Link
US (1) US6951843B2 (de)
EP (1) EP1333024B1 (de)
JP (1) JP4601249B2 (de)
KR (1) KR100559306B1 (de)
CN (1) CN1194006C (de)
AT (1) ATE420067T1 (de)
AU (1) AU782470B2 (de)
CA (1) CA2396678C (de)
DE (1) DE60137352D1 (de)
WO (1) WO2002036551A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2465080A1 (en) 2001-11-16 2003-05-22 Kenji Yamamoto Peptide derivative and pharmaceutically acceptable salts thereof, and production process and use thereof
CN100446522C (zh) * 2005-10-28 2008-12-24 环达电脑(上海)有限公司 Pda设备上基于蓝牙技术实现手机免提通话的方法
JP5397851B2 (ja) * 2009-05-21 2014-01-22 Ｎｓマテリアルズ株式会社 ペプチド誘導体又はその塩の製造方法
WO2017201322A1 (en) * 2016-05-19 2017-11-23 Cortexyme, Inc. Treatment of osteoarthritis with gingipain blocking agents

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341029C (en) 1985-02-04 2000-06-20 Michael Kolb Peptidase inhibitors
US5496927A (en) * 1985-02-04 1996-03-05 Merrell Pharmaceuticals Inc. Peptidase inhibitors
JPH0597708A (ja) 1991-10-02 1993-04-20 Lion Corp 歯周病治療剤
US6100380A (en) * 1991-10-28 2000-08-08 Cytran, Inc. Immunomodulating peptides and methods of use
US6066622A (en) * 1991-10-28 2000-05-23 Cytran, Inc. Immunomodulating peptides and methods of use
JP3873429B2 (ja) 1998-02-20 2007-01-24 大鵬薬品工業株式会社 ペプチド誘導体及びその薬学的に許容される塩、その製造方法及びその用途
AU2002211649A1 (en) * 2000-10-11 2002-04-22 Targesome, Inc. Targeted therapeutic agents

Also Published As

Publication number Publication date
KR100559306B1 (ko) 2006-03-15
US6951843B2 (en) 2005-10-04
AU1270402A (en) 2002-05-15
CN1394199A (zh) 2003-01-29
EP1333024A4 (de) 2005-11-16
CA2396678C (en) 2009-01-20
EP1333024B1 (de) 2009-01-07
ATE420067T1 (de) 2009-01-15
JPWO2002036551A1 (ja) 2004-03-11
CN1194006C (zh) 2005-03-23
CA2396678A1 (en) 2002-05-10
AU782470B2 (en) 2005-08-04
JP4601249B2 (ja) 2010-12-22
WO2002036551A1 (fr) 2002-05-10
KR20020067597A (ko) 2002-08-22
US20030087828A1 (en) 2003-05-08
EP1333024A1 (de) 2003-08-06

Similar Documents

Publication Publication Date Title
DE60236600D1 (de) Substituierte 1h-dihydropyrazole, ihre herstellung und verwendung
ATE253545T1 (de) Biarylessigsäure-derivate und ihre verwendung als cox-2 inhibitoren
IL150650A0 (en) Piperidine derivatives and pharmaceutical compositions containing the same
EP1462447A3 (de) Verfahren zur Herstellung von reinem Citalopram
DE69705829T2 (de) Meta-substituierte phenylsulphonamidderivate
ATE212978T1 (de) Para-substituierte phenylpropansäure derivate als integrin-antagonisten
CA2446944A1 (en) Anti-inflammatory and immunomodulatory amino acid derivatives, their preparation and use
DK0894084T3 (da) Kanelsyrederivater og deres anvendelse som integrinantagonister
IS6257A (is) Frumuviðloðunartálmar
YU101302A (sh) Derivat benzoilpiridina ili njegova so, fungicid koji ga sadrži u vidu aktivnog sastojka, postupak za njegovu proizvodnju i intermedijer za njegovo dobijanje
AU7517400A (en) N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent
DE59408399D1 (de) Arylessigsäurederivate und ihre verwendung als fungizide
ATE13178T1 (de) 2-oxoazetidin-derivate, ihre herstellung und verwendung.
ATE297903T1 (de) Substituierte phenyluracile
DE69510338D1 (de) Azirdin-derivate, deren herstellung und verwendung
DE60137352D1 (de) Nsalze, verfahren zur herstellung von beiden und ihre verwendung
DE69330601D1 (de) Serotoninergische ergolin derivate
ATE403376T1 (de) Insektizid sowie verfahren zur bekämpfung von insekten
AU655869B2 (en) An amphoteric tricyclic compound
DE69504198T2 (de) Substituierte alkyldiaminderivate und ihre verwendung als tachykinin antagonisten
DE60214414D1 (de) Peptidderivat, pharmazeutisch unbedenkliches salz davon, verfahren zu dessen herstellung und dessen verwendung
CO5150221A1 (es) Nuevas 3-fenoxi- y 3-fenilalquiloxi-2-fenil-propilaminas sustituidas
PT1423385E (pt) Intermediários para preparar conjugados inibidores da neuraminidase
FR2854632A1 (fr) Synthese de composes heterocycliques substitues
AU1847401A (en) Diketopiperazine derivatives to inhibit thrombin

Legal Events

Date Code Title Description
8364 No opposition during term of opposition